Avalanche (AVAX) and Injective (INJ) have surged with double-digit rallies over the week, showcasing impressive strength in the market. As these tokens rise, a new DeFi gem known as DTX Exchange (DTX), is catching significant attention.
With its cutting-edge 100,000 TPS blockchain and $3 million raised in its ongoing presale, DTX is positioning itself as the next big player in the DeFi space. Could DTX be the next breakout star?
Avalanche (AVAX) Soars Ahead of Major Upgrade: A Promising Future Unfolds
Avalanche (AVAX) has demonstrated notable resilience, climbing 10% in the seven days as excitement builds around the blockchain’s first major upgrade. Data from TradingView reveals that AVAX broke through the critical 200-day exponential moving average (EMA) on September 26, hitting an intraday high of $29.10.
Moreover, the Avalanche Foundation unveiled Avalanche9000, described as the “largest network upgrade” since the blockchain’s mainnet launch in September 2020. As a result, market experts anticipate further gains in the value of Avalanche (AVAX), as this upgrade will improve the scalability, cost-efficiency, and enrich the developer experience.
DTX Exchange: Poised for a Double-Digit Rally with Its Groundbreaking 100,000 TPS Blockchain
With the recent release of its new Layer 1 blockchain, which offers an amazing 100,000 transactions per second (TPS), DTX Exchange (DTX) is poised for a possible double-digit surge. The DTX blockchain will draw users and investors looking for quick, low-cost transactions by virtue of such great TPS capabilities, hence increasing its market attractiveness.
The DTX ecosystem includes not only cryptocurrencies but also traditional financial products such as equities, ETFs, and bonds. This diverse offering provides many trading options which are suitable for a wider audience and a better user experience. DTX will change how users interact with digital assets by connecting creative Web3 products with conventional banking.
Additionally, DTX Exchange features VulcanX, a gas-free trading alternative that simplifies trading procedures, thereby improving customer pleasure. With its mainnet launch and commitment to real-world solutions, DTX Exchange is well-positioned to capitalize on the growing demand for flexible and efficient trading platforms.
Latest Developments in Injective: Price Surge Amid Market Decline
Injective (INJ) has been making headlines by outperforming the broader cryptocurrency market, gaining over 19% since Monday. While many cryptocurrencies have faced declines, INJ is currently trading around $19.38, marking a significant recovery from yearly lows near $15.
This rally has allowed the token to break above the 4-hour 200 exponential moving average (EMA) for the first time since late August, highlighting a potential shift in market strength. The 4H 200 EMA is a key indicator for assessing short-term bullish momentum. If Injective (INJ) can successfully retest and maintain its position above this level, it may signal further upward movement, targeting resistance zones near $23.
Comparing Blockchain Powerhouses: Why DTX Exchange Outshines Avalanche and Injective
Avalanche (AVAX), Injective (INJ), and DTX Exchange each have unique strengths in the blockchain space. While Injective emphasizes distributed trading, Avalanche is well-known for its scalability and quick transaction times.
However, DTX Exchange (DTX) stands out with its newly launched Layer 1 blockchain capable of processing 100,000 transactions per second, significantly surpassing both Avalanche and Injective.
The platform also brings traditional financial products to Web3, thus improving customer experience and usability. Gas-less trading, blockchain fiat bridge and high speed of trades are the solutions DTX Exchange has to offer for the problems of the traditional and centralized trading market.
Learn more:
Disclaimer: This is a sponsored press release for informational purposes only. It does not reflect the views of Times Tabloid, nor is it intended to be used as legal, tax, investment, or financial advice. Times Tabloid is not responsible for any financial losses.
